RecruitingPhase 1NCT05679895

Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
OneChain Immunotherapeutics
Intervention
CD1a-CAR T(biological)
Enrollment
20 enrolled
Eligibility
2 years · All sexes
Timeline
20232027

Study locations (2)

Collaborators

BioClever 2005 S.L. · Hospital Clinic of Barcelona · Hospital Sant Joan de Deu · Astrum CRO, S.L.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05679895 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials